Chagas disease (CD) is a neglected tropical disease caused by the protozoan haemoflagellate parasite *Trypanosoma cruzi*, which afflicts about eight million individuals in Latin America ([@B46]). In most patients, the establishment of immune response and inflammatory processes in the heart tissue are associated with parasite control and restoration of homeostasis in the acute phase of CD. However, in approximately 30% of patients, the inflammation progresses and results in chronic chagasic cardiomyopathy (CCC), characterised by focal and diffuse inflammation, parasite persistence, myocytolysis and progressive fibrosis with remodelling of the myocardium and vasculature, which commonly results in heart failure ([@B33], [@B46]). Plasma levels of tumour necrosis factor (TNF) are correlated with the severity of chronic CD ([@B42]) and the degree of left ventricular dysfunction in patients with CCC ([@B23], [@B53]). During acute infection, TNF alone or in association with other cytokines is proposed to control of parasite replication via the release of nitric oxide (NO) by macrophages ([@B3]) and cardiomyocytes ([@B34]). However, the elevated TNF levels in chronic CD patients may contribute to heart tissue damage and CCC ([@B42], [@B31]). NO is an important cytotoxic and cytostatic factor in cell-mediated immunity to intracellular pathogens ([@B11]). Nevertheless, excessive NO production may cause host injury, including a reduction in myocardial contractibility ([@B20]). Recently, inducible NO synthase (iNOS/NOS2) expression in cardiac tissue and NO overproduction were shown to be associated with the severity of heart injury and electrical abnormalities in chronically infected rhesus monkeys ([@B13]).

More than a century after the celebrated discovery by [@B15], there are still gaps in the knowledge of CD pathophysiology. Furthermore, the therapeutic tools used to treat chronic patients only mitigate symptoms of Chagas' heart disease; therefore, new therapeutic agents are needed ([@B30]). In research aimed at elucidating the pathophysiology of CD or to screen potential therapeutic agents, chronic infection with *T. cruzi* reproduced myocarditis and fibrosis in experimentally-infected dogs (de [@B16]), mice ([@B21], [@B5]), hamsters ([@B45]) and monkeys ([@B14], [@B13]). Furthermore, some aspects of the electrical abnormalities associated with chronic CD were reproduced in rabbits ([@B24]), mice ([@B48], [@B50]), dogs ([@B9]) and monkeys ([@B47], [@B14], [@B13]). Consider amounts of data were collected that helped to advance the knowledge of CD pathogenesis and to test trypanocidal drugs ([@B10], [@B7]). Recently, the dog model has reemerged as a potent tool for examining the pathogenesis of chronic CD due to the great similarity between some of the pathologies and immunological alterations common to both CD patients and *T. cruzi*-infected dogs ([@B25]). Furthermore, rhesus monkeys replicate important cardiac and immunological aspects of Chagas' heart disease ([@B14], [@B13]). However, the canine and non-human primate experimental models of CD require special facilities, are difficult to manage, expensive to keep and restricted to a few research groups. Therefore, reasonable experimental models that simultaneously reproduce relevant parasitological and clinical aspects and immunological abnormalities associated with chronic Chagas' heart disease are needed to advance the understanding of CD pathophysiology and the search for biomarkers of CD progression and to test therapeutic agents. The aim of our work was to establish realistic experimental models of varying severity that reproduce the parasitological, histopathological and clinical aspects of chronic Chagas' heart disease using two mouse lineages infected with the myotropic Colombian *T. cruzi* Type I strain ([@B21], [@B56]). Furthermore, we tested the association between the severity of heart disease and the serum TNF and NO levels of these experimental mouse models of chronic *T. cruzi* infection.

MATERIALS AND METHODS
=====================

*Mouse models of chronic infection by T. cruzi* - Five to seven-week-old female C3H/He (H-2^k^) and C57BL/6 (H-2^b^) mice obtained from the animal facilities \[Laboratory Animals Breeding Center, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil\] were maintained under specific pathogen-free conditions. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Brazilian National Council of Animal Experimentation ([cobea.org.br/]{.ul}) and the Federal Law 11.794 (8 October 2008). The institutional Committee for Animal Ethics of Fiocruz (license 004/09) approved all of the procedures used in this study.

*Experimental infection* - Mice were infected intraperitoneally with 100 blood trypomastigotes of the Colombian strain of *T. cruzi*, isolated from a human patient in Colombia ([@B21]) and genotypically characterised as a *T. cruzi* Type I strain ([@B56]). Parasitaemia was estimated using 5 μL of blood obtained from the tail vein, employed as a parameter to establish the acute and chronic phases of infection (dos [@B18]). In all sets of experiments, three-five sex and age-matched non-infected (NI) controls were analysed per time point in parallel with five-10 infected mice at 70 days post-infection (dpi), 120 dpi or 150 dpi, according to the experimental protocol.

*Reagents and antibodies* - For immunohistochemistry (IHS), staining the polyclonal antibody recognising *T. cruzi*antigens and the anti-mouse CD8a (53-6.7) and anti-mouse CD4 (GK1.5) supernatants were produced in our laboratory (Laboratory of Biology of the Interactions, Oswaldo Cruz Institute, Fiocruz). The anti-F4/80 polyclonal antibody recognising macrophages was purchased from Caltag (USA). The polyclonal rabbit antibody recognising connexin 43 (Cx43) was purchased from Sigma (USA). The polyclonal rabbit antibody recognising mouse fibronectin (FN) was obtained from Gibco-BRL (USA). The biotinylated anti-rat immunoglobulin was obtained from DAKO (Denmark) and the biotinylated anti-rabbit immunoglobulin and peroxidase-streptavidin complex were purchased from Amersham (England). For IHS, appropriate controls were prepared by replacing primary antibodies with rat immunoglobulin or normal rabbit serum. All antibodies and reagents were utilised in compliance with the manufacturers' instructions.

*Histopathology and IHS*- Groups of five-eight infected and three-five NI control mice were killed under anaesthesia at 120 dpi or 150 dpi, according to the experimental protocols. In a series of experiments, the hearts of the mice were collected, fixed in 10% formaldehyde, processed for histopathology, embedded in paraffin and subjected to haematoxylin and eosin staining. In another set of experiments, the hearts were removed, embedded in tissue-freezing medium (Tissue-Tek, Miles Laboratories, USA) and stored in liquid nitrogen until use. Serial cryostat sections, 3 μm-thick, were fixed in cold acetone and subjected to indirect immunoperoxidase staining for the characterisation of inflammatory cells, as previously described (dos [@B18]). The IHS assay for detection of *T. cruzi* heart tissue parasitism was performed and analysed as previously described ([@B50]). The FN and Cx43-positive areas in 25 fields (12.5 mm^2^) per section, in three sections per heart, were evaluated with a digital morphometric apparatus. Images were digitised using a colour view XS digital video camera adapted to a Zeiss microscope. The images were analysed with AnalySIS AUTO software (Soft Imaging System, USA). The areas that expressed the molecule of interest were integrated with the areas that did not express the molecule of interest and the data were presented as the percentage of the positive area in the heart, as the distance (μm) between stained gap junctions or as parasite nests or cell numbers/100 microscopic fields (400X).

*Detection of cardiac muscle creatine-kinase isoform* - The activity of the creatine kinase cardiac MB isoenzyme (CK-MB) was measured using a commercial CK-MB Liquiform kit (Labtest, Brazil) in accordance with the manufacturer's recommendations and has been previously adopted for an experimental approach in a murine model of chronic infection ([@B37], [@B50]).

*Electrocardiogram (ECG) registers* - All mice were intraperitoneally tranquilised with diazepam (10 mg/Kg) and transducers were carefully placed subcutaneously according to the chosen preferential derivation (DII). Two-minute long traces were recorded using the digital system Power Lab 2/20, which was connected to a bio-amplifier at 2 mV for 1 s (PanLab Instruments, Spain). Filters were standardised to between 0.1-100 Hz and traces were analysed using the Scope software for Windows v.3.6.10 (PanLab Instruments, Spain). The ECG parameters were analysed as previously described ([@B50]).

*Serum TNF determination* - The TNF serum concentrations were evaluated by ELISA kits for the detection of mouse TNF (R&D Systems, USA) according to the manufacturer's protocols. The colourimetric reaction was assessed using an ELISA plate reader at 490 nm (ASYS Hitech GmbH, Austria). In addition, a mouse cytometric bead array (CBA Inflammation Kit, Becton & Dickinson, USA) was used to quantify TNF in the serum according to the manufacturer's instructions. The fluorescence produced by the CBA beads was measured on a FACSCalibur (Becton Dickinson, USA) and analysed using the FCAP Array software. Standard curves (1-100 ng/mL) were created in parallel. These methods consistently detected concentrations above 10 pg/mL.

*NO quantification* - Nitrate and nitrite (NO~x~) were determined in serum samples from NI and infected mice using the Griess reagent and vanadium chloride III with a standard curve of 0.8-100 µM NaNO~2~ and NaNO~3~ ([@B13]).

*Statistical analysis* - Data are expressed as arithmetic means ± standard deviation. Student's *t*, ANOVA or other more appropriate tests were used to analyse the statistical significance of the observed differences. The Kaplan-Meier method was used to compare the survival times of the studied groups. All statistical tests were performed using GraphPad Prism. Differences were considered statistically significant when p \< 0.05.

RESULTS
=======

*T. cruzi-infected C3H/He mice present higher parasitaemia, inflammation and heart parasitism than infected C57BL/6 mice*- When female C57BL/6 and C3H/He mice were infected with a low inoculum of the Colombian *T. cruzi* Type I strain ([Fig. 1A](#f01){ref-type="fig"}), circulating parasites were first detected at 14 dpi. However, the C3H/He animals showed higher numbers of parasites at the peak of parasitaemia, which occurs at 42-45 dpi in both mouse lineages ([Fig. 1B](#f01){ref-type="fig"}). Furthermore, in both models of parasitaemia, control occurs from 60-70 dpi. Approximately 70-85% of the C57BL/6 and C3H/He mice survived ([Fig. 1C](#f01){ref-type="fig"}) without trypanocidal treatment and developed a chronic infection when the rare blood trypomastigote was found at 90 dpi. In all surviving animals, focal and diffuse inflammatory infiltrates and remodelling of the cardiac tissue were detected in chronically infected C57BL/6 and C3H/He mice, compared with age-matched NI controls ([Fig. 1D](#f01){ref-type="fig"}). The chronic myocarditis was mainly composed of CD8^+^, CD4^+^ lymphocytes and F4/80^+^ macrophages were detected in the chronic phase of infection occurring at 120 dpi and 150 dpi (data not shown) in mice of both lineages, corroborating previous findings ([@B52], dos [@B18], [@B50]). Importantly, total heart inflammation, representing the sum of CD8^+^ and CD4^+^ T-cell subsets and macrophages, was more pronounced in chronically *T. cruzi*-infected C3H/He mice compared to infected C57BL/6 mice ([Fig. 1E](#f01){ref-type="fig"}). Notably, heart parasitism persisted during the chronic phase of infection, being more intense in C3H/He mice compared to C57BL/6 mice ([Fig. 1F](#f01){ref-type="fig"}).

Fig. 1: *Trypanosoma cruzi* parasitism and inflammation persist in the heart tissue of chronically infected mice. A: experimental design of the article. C57BL/6 and C3H/He mice were infected with 100 blood trypomastigotes (bt) of the Colombian *T. cruzi* Type I strain and analysis at 70 days post-infection (dpi), 120 dpi or 150 dpi, according experimental protocol; B: kinetics of parasitaemia; C-D: quantitative data of the immunohistochemistry for *T. cruzi* parasite nests (C) and total inflammatory cells (D) in the heart tissue at 120 dpi; \#: p \< 0.05 C57BL/6 mice compared to C3H/He mice. Data obtained from three independent experiments \[5 non-infected (NI) and eight-10 *T. cruzi*-infected mice per experiment\].

*Cardiac tissue injury is more severe in T. cruzi-infected C3H/He mice compared to infected C57BL/6 mice*- In six-month-old NI controls, the expression of Cx43, a marker of cardiomyocyte connectivity ([@B39]), was regular and organised ([Fig. 2A](#f02){ref-type="fig"}). However, in chronically (150 dpi) *T. cruzi*-infected mice, the expression of Cx43 was reduced, disorganised and more disperse ([Fig. 2A](#f02){ref-type="fig"}) and was characterised by an increased distance between the marks for Cx43 in the intercalated disks of the cardiomyocytes ([Fig. 2B](#f02){ref-type="fig"}). In parallel experiments, the Cx43 disorganisation was increased in six-month-old NI C3H/He mice compared to C57BL/6 mice ([Fig. 2B](#f02){ref-type="fig"}). Furthermore, the Cx43 disorganisation was more extensive in *T. cruzi*-infected C3H/He mice compared to infected C57BL/6 mice ([Fig. 2B](#f02){ref-type="fig"}).

Fig. 2: *Trypanosoma cruzi* induces connexin 43 (Cx43) loss during the chronic phase of infection. A: representative sections of the heart tissue of non-infected (NI) and infected C57BL/6 mice analysed by immunohistochemistry for detection of Cx43 at 150 days post-infection; B: quantitative data of Cx43-containing gap junction distances in the heart tissue of NI and *T. cruzi*-infected C57BL/6 and C3H/He mice; \*\*: p \< 0.01, NI compared to *T. cruzi*-infected mice; \#: p \< 0.05, C57BL/6 compared to C3H/He lineage. Data obtained from three independent experiments (5 NI and 8-10 *T. cruzi*-infected mice per experiment).

When compared to NI controls, increase deposition of the extracellular matrix component FN ([@B36]) was detected in the heart tissue of C57BL/6 and C3H/He mice infected with the Colombian *T. cruzi* strain ([Fig. 3A](#f03){ref-type="fig"}, [B](#f03){ref-type="fig"}). The FN expression was similar in six-month-old NI C57BL/6 and C3H/He mice, the parallel controls of the infected mice ([Fig. 3A](#f03){ref-type="fig"}). At 150 dpi, however, the FN deposition in the cardiac tissue was more intense in *T. cruzi*-infected C3H/He mice compared to infected C57BL/6 mice ([Fig. 3B](#f03){ref-type="fig"}).

Fig. 3: *Trypanosoma cruzi* induces fibronectin (FN) deposition in the cardiac tissue during the chronic phase of infection. A: representative sections of the heart tissue of non-infected (NI) and infected C57BL/6 mice analysed by immunohistochemistry for FN deposition; B: quantitative data of FN-stained area (%) in the heart tissue of NI and *T. cruzi*-infected C57BL/6 and C3H/He mice; \*\*\*: p \< 0.001, NI compared to *T. cruzi*-infected mice; \#: p \< 0.05, C57BL/6 compared to C3H/He lineage. Data obtained from three independent experiments (3 NI and 5 *T. cruzi*-infected mice per experiment).

CK-MB activity, which is proportional to the concentration of the enzyme present in the serum and assumed to be a marker of myocardial injury ([@B1]), was increased in the serum of chronically (150 dpi) *T. cruzi*-infected C3H/He and C57BL/6 mice compared with sex and age-matched NI controls ([Fig. 4](#f04){ref-type="fig"}). Again, the levels of CK-MB activity were elevated in the serum of *T. cruzi*-infected C3H/He mice compared to infected C57BL/6 mice ([Fig. 4](#f04){ref-type="fig"}).

Fig. 4: *Trypanosoma cruzi* induces cardiomyocyte lesion during the chronic phase of infection. Enzymatic evaluation of creatine kinase cardiac MB isoenzyme (CK-MB) activity in the serum of non-infected (NI) and *T. cruzi*-infected C57BL/6 and C3H/He mice at 150 days post-infection. Data obtained from three independent experiments (3-5 NI and 6-8 *T. cruzi*-infected mice per experiment). OD: optical density; \*: p \< 0.05; \*\*: p \< 0.01, NI compared to *T. cruzi*-infected mice; \#: p \< 0.05, C57BL/6 compared to C3H/He lineage.

*Electrocardiograph alterations are severe in T. cruzi-infected C3H/He mice*- Disturbances in electrical conduction are striking features of Chagas' heart disease ([@B46]). The normal P wave and the QT complex register ([Fig. 5A](#f05){ref-type="fig"}) were altered in chronically (150 dpi) *T. cruzi*-infected mice compared with sex and age-matched NI controls. Infected mice presented ECG abnormalities in the conduction system, including a prolonged P wave, PR interval and QRST complex ([Fig. 5B](#f05){ref-type="fig"}). The duration of the QRS interval was similar in six-month-old NI C57BL/6 and C3H/He control mice. At 150 dpi, significant alteration of the QRS interval was detected in *T. cruzi*-infected C57BL/6 and C3H/He mice compared with their NI controls ([Fig. 5C](#f05){ref-type="fig"}). Additionally, the prolonged QRS interval was more pronounced in infected C3H/He mice compared to C57BL/6 mice (p \< 0.01). In both mouse lineages, *T. cruzi*-infected mice frequently show ECG alterations such as arrhythmias (ARTs) and a second-degree atrioventricular block (AVB2). Moreover, a low frequency of infected C3H/He and C57BL/6 mice also presented with an AVB1, while fibrillation was rarely (\< 5%) detected in infected mice of either lineage. Therefore, *T. cruzi*-infected mice frequently (80% for C57BL/6 and 100% for C3H/He) showed ECG abnormalities ([Fig. 5D](#f05){ref-type="fig"}). Altogether, the ECG abnormalities were more frequent and severe in *T. cruzi*-infected C3H/He mice compared to infected C57BL/6 mice.

Fig. 5:*Trypanosoma cruzi* induces electrocardiographic (ECG) abnormalities during the chronic phase of infection. A: schematic representation of the P wave and QT complex segment of the ECG register of a non-infected (NI) mice; B: representative ECG register segments of sex and age-matched NI controls and *T. cruzi*-infected C3H/He mice at 150 days post-infection; C: data for ECG records showing the duration (ms) of the QRS interval; D: summary of the group data for the frequency of NI and *T. cruzi*-infected mice presenting arrhythmias (ARTs), second-degree atrioventricular block (AVB2) and total ECG alterations; \*\*: p \< 0.01, NI compared to *T. cruzi*-infected mice; \#: p \< 0.05, C57BL/6 compared to C3H/He lineage. Data obtained from three independent experiments (5 NI and 8-10 *T. cruzi*-infected mice per experiment).

*High TNF and NO levels are detected in the serum of Colombian-infected C3H/He and C57BL/6 mice*- Compared with six-month-old matched NI controls, the serum TNF levels of chronically (150 dpi) *T. cruzi*-infected C57BL/6 and C3H/He mice were significantly increased ([Fig. 6](#f06){ref-type="fig"}). Moreover, while the slight increase in the TNF levels in the serum of NI C3H/He mice compared to NI C57BL/6 mice was not significant (p \> 0.05), the TNF levels were eight-12-fold higher in *T. cruzi*-infected C3H/He mice compared to infected C57BL/6 mice (p \< 0.05) ([Fig. 6](#f06){ref-type="fig"}).

Fig. 6: *Trypanosoma cruzi* induces increased tumour necrosis factor (TNF) levels during the chronic phase of infection. Detection of TNF concentrations in the serum of non-infected (NI) and *T. cruzi*-infected C57BL/6 and C3H/He mice. Representative data obtained from two independent experiments using ELISA and CBA Inflammation Kit (3 NI and 5 *T. cruzi*-infected mice per experiment). \*: p \< 0.05, NI compared to *T. cruzi*-infected mice.

Considering that NO is proposed to control *T. cruzi* growth during acute infection ([@B49]), we measured the serum nitrate/NO~x~ concentrations of mice after parasitaemia control, which occurs at 60-70 dpi ([Fig. 1B](#f01){ref-type="fig"}). At 70 dpi, NO~x~levels were increased in the serum of infected mice of either lineage in comparison with their NI sex and age-matched controls ([Fig. 7](#f07){ref-type="fig"}). Furthermore, the NO~x~ levels in the serum of *T. cruzi*-infected C3H/He mice were higher than in the serum of infected C57BL/6 mice ([Fig. 7](#f07){ref-type="fig"}).

Fig. 7: *Trypanosoma cruzi* infection increased nitric oxide (NO) levels in the serum. Concentrations of nitrate/nitrite were measured in the serum of non-infected (NI) and *T. cruzi*-infected C57BL/6 and C3H/He mice at 70 days post-infection, using modified Griess methodology. Data obtained from three independent experiments (3 NI and 3-5 *T. cruzi*-infected mice per experiment). \*: p \< 0.05; \*\*: p \< 0.01, NI compared to *T. cruzi*-infected mice; \#: p \< 0.05, C57BL/6 compared to C3H/He lineage.

*The severity of cardiac tissue injury and ECG abnormalities parallels the TNF and NO levels in the serum during T. cruzi infection* - Finally, all the analysed parameters were comparatively scored for each of the four groups studied (NI and *T. cruzi*-infected C57BL/6 and C3H/He mice). As summarised in Table, analysis of the different markers of heart injury and electrical abnormalities during the chronic *T. cruzi* infection revealed that these alterations are more intense in C3H/He mice compared with C57BL/6 mice. Importantly, the intensity of chronic heart tissue injury and severity of ECG abnormalities paralleled the TNF and NO~x~ levels in the serum of infected C57BL/6 and C3H/He mice ([Table](#t01){ref-type="table"}).

TABLEComparative study of cardiac and immunological alterations in *Trypanosoma cruzi*-infected C57BL/6 and C3H/He miceParametersC57BL/6C3H/HeNI*T. cruzi*NI*T. cruzi*Parasitism^*a*^-+-+++Inflammation^*a*^-+-+++Cx43 loss^*a*^++++++++++FN deposition^*a*^++++++++CK-MB activity^*b*^+++++++ECG alterations-++-+++TNF^*b*^+++++++++++NO^*b*^+++++++[^1]

DISCUSSION
==========

In the present study, we propose two reasonable experimental models with differing degrees of *T. cruzi*-induced chronic cardiomyopathy that are supported by parasitological, histopathological, biochemical and electrocardiographic findings. Furthermore, we show that the severity of experimental Chagas' heart disease parallels the TNF and NO levels in the serum. Thus, these models reproduce, for the first time, the parallelism between the clinical severity and two relevant immunological features described in chronic cardiopathic CD patients.

The search for a suitable experimental animal model that reproduces the parasitological and clinical aspects of CD was initiated soon after the discovery of the disease ([@B15], [@B54]). Although several studies were carried out using different animal models that reproduce aspects of the chronic disease ([@B33], [@B21], [@B5], [@B24], [@B48], de [@B16], [@B47], [@B45], [@B9], [@B14], [@B13], [@B50]), reasonable experimental models that simultaneously reproduce relevant parasitological and clinical aspects of the chronic Chagas' heart disease in association with immunological abnormalities are still needed.

In trying to prove a causal relationship of the parasite strain to the heart disease, [@B21] used a *T. cruzi* strain (Colombian) isolated from a human patient in Colombia and the inbred C3H/He mouse lineage. In this study, parasitaemia peak occurred after 30 dpi and parasite control occurred by 60 dpi, as corroborated by our results. Furthermore, loss of cardiomyocytes and replacement by fibrosis in the presence of focal necrosis and inflammation was observed during chronic infection ([@B21]), resembling features of Chagas' heart disease ([@B26]). Later, the model of Colombian-infected C3H/He mice was shown to reproduce the CD8-enriched chronic *T. cruzi*-induced myocarditis (dos [@B18]) and was used to study the cellular and molecular mechanisms of heart tissue colonisation by inflammatory cells ([@B35], [@B29], [@B37]). The infection of C57BL/6 mice with the Colombian strain also reproduces the CD8-enriched chronic myocarditis ([@B52]), as well as important aspects of the CD electrocardiographic abnormalities ([@B50]). This collection of data showed that C3H/He and C57B/6 mice infected by the Colombian strain reproduce relevant features of CCC. However, studies comparing these models with regards to the features of CCC such as parasitism, inflammation, biomarkers of heart injury and electrical abnormalities were not previously performed. Furthermore, a study of immunological mediators associated with CCC in prior studies ([@B23], [@B42], [@B53], [@B13]) was also missing in these models. Mice of the C57BL/6 and C3H/He lineages infected with a low inoculum of the Colombian strain survived the acute phase and developed chronic infections with persistent heart parasitism and low grade CD8^+^ T-cell-enriched inflammation, corroborating previous findings ([@B52], dos [@B18], [@B37], [@B50]). Moreover, experiments performed in parallel showed that C3H/He mice were more susceptible to the acute phase, with higher parasitaemia. However, mice of both lineages similarly survived and developed chronic infections, although C3H/He mice presented higher cardiac parasitism and inflammation than their C57BL/6 counterparts.

Next, we used biomarkers of heart injury to compare the extent of the tissue lesions in the C3H/He and C57BL/6 models of chronic *T. cruzi* infection. An intense Cx43 disorganisation in the heart tissue was detected in chronically infected C3H/He and C57BL/6 mice compared with their NI controls. Furthermore, infected mice showed distinguishable degrees of Cx43 disorganisation, which was more intense in the C3H/He lineage compared to C57BL/6 mice. Previous data showed that acute *T. cruzi* infection induces Cx43 disorganisation and remodelling, with delocalisation of the connexin plaques from the intercalated discs and lateralisation ([@B29], [@B2]). The Cx43 lateralisation accompanies electrical alterations in myocardial infarction and heart failure ([@B19]). Moreover, there is an association between disorganisation and loss of Cx43, the most abundant ventricular gap junction protein and arrhythmogenic diseases ([@B39]). Importantly, Cx43 expression is down regulated in patients with CCC ([@B55]) and chronically *T. cruzi*-infected monkeys ([@B13]), supporting the conservation of this feature in different species subjected to *T. cruzi* infection. Thus, both experimental murine models used in our study reproduce this relevant aspect of CCC.

Chagas' heart disease may be considered a progressive fibrotic disorder ([@B26]). Enhanced deposition of extracellular matrix components, including FN, characterises the cardiac tissue fibrosis that develops during chronic *T. cruzi* infection in mice ([@B6], dos [@B18]) and patients ([@B28]). Furthermore, a higher frequency of CD patients with heart failure present severe fibrosis, myocarditis and myocardial hypertrophy compared to indeterminate-form patients ([@B27]). Our studies showed for the first time that it was possible to discriminate between experimental models of chronic *T. cruzi* infection having intense (C3H/He) and slight (C57BL/6) FN deposition, which paralleled the degree of heart inflammation and therefore resembled CD patients ([@B27]). Although FN expression was down regulated in *T. cruzi*-bearing cardiomyocytes in vitro ([@B12]), the presence of the parasite and its antigens triggered the production of FN in skeletal muscle cells ([@B44], [@B36]). In benznidazole-treated mice, reduced heart parasitism is accompanied by decreased FN deposition and fibrosis ([@B8]), supporting a parallelism between heart parasitism and FN expression. Furthermore, FN promotes *T. cruzi* adhesion to and uptake by macrophages and fibroblasts ([@B40], [@B38]) and may perpetuate heart parasitism. In this context, the differential degree of FN deposition detected in the heart tissue of C3H/He and C57BL/6 mice paralleled the intensity of heart parasitism and may reflect a causal relationship. This idea deserves to be explored.

Serum CK-MB activity is an important non-invasive biomarker of cardiomyocyte lesions in both acute (de [@B17], [@B29]) and chronic ([@B37], [@B13]) experimental chagasic cardiomyopathy. In our current findings, the intensity of the cardiomyocyte lesion, as revealed by increased levels of serum CK-MB activity, is more severe in infected C3H/He compared to C57BL/6 mice and is related to the degree of inflammation, FN deposition and Cx43 disorganisation in the heart tissue. Additionally, our data reinforce the applicability of CK-MB activity as a biomarker for distinguishing between degrees of heart tissue damage in chronic *T. cruzi* infection.

Both C3H/He and C57BL/6 CCC models reproduced the ECG abnormalities, primarily ARTs and first and second-degree AVBs, detected in chronically *T. cruzi*-infected patients ([@B46]). Furthermore, a prolonged QRS interval was detected in chronically Colombian-infected C57BL/6 and C3H/He mice compared with their NI controls. Interestingly, the QRS score directly correlates with cardiac fibrosis, as revealed by magnetic resonance myocardial scar size and inversely correlated with left ventricular ejection fraction in chronic chagasic patients ([@B51]). Furthermore, in Colombian-infected rhesus monkeys with CCC, the intensity of fibrosis has been shown to be related to the severity of electrical abnormalities ([@B13]). When comparing chronically infected C57BL/6 and C3H/He mice, the severity of the ECG abnormalities, particularly regarding the prolonged QRS intervals, was directly related to the extent of FN deposition and Cx43 disorganisation in heart tissue and levels of CK-MB activity in the serum. Therefore, the non-invasive ECG register should be further explored and validated as a tool reflecting the magnitude of myocardial scar in Chagas' heart disease, as proposed by [@B51] and supported by our data. Moreover, the Colombian-infected C3H/He and C57BL/6 models may increase the understanding of the pathophysiological causal relationship between myocardial scar and ECG alterations.

There is a consensus that CD is a multifactorial disorder, in which *T. cruzi* persistence and parasite-driven deregulated immune responses are key players in the establishment of CCC ([@B32]). Serum TNF levels correlated with CD severity ([@B42]) and the degree of cardiac dysfunction in patients with CCC ([@B23], [@B53]). Chronically *T. cruzi*-infected C57BL/6 and C3H/He mice have increased expression of TNF mRNA and protein in the heart tissue ([@B52], dos [@B18], [@B37]). Importantly, we show that C57BL/6 and C3H/He mice present a range of TNF levels in the serum paralleling the intensities of cardiac tissue injury and ECG abnormalities and thus mimicking features of CD patients with different degrees of CCC severity ([@B23], [@B53]). Increased TNF concentrations can directly damage myocardial cells and may be responsible for the pathogenesis of advanced heart failure ([@B22]). In *T. cruzi* infection, experiments using an anti-TNF blocking antibody have implicated TNF as trigger of parasite-induced acute heart injury characterised by Cx43 disorganisation, increased serum CK-MB activity ([@B29]) and chronic CD8-enriched myocarditis ([@B41]). Altogether, these data reinforce the importance of the Colombian-infected C57BL/6 and C3H/He mouse models for the further exploration of the pathophysiological role of TNF in CCC.

According to [@B42], the pathophysiology of CD is associated with enhanced TNF and NO production. Furthermore, high NO levels in the serum are associated with the severity of heart injury and electrical and echocardiographic alterations in chronically infected rhesus monkeys ([@B13]). Infection with *T. cruzi*, especially occurring in a cytokine-enriched milieu, induces NO expression by macrophages and cardiomyocytes ([@B3], [@B34]). However, the molecular mechanisms leading to exacerbated NO production in CD are not fully understood. In acute infection, NO plays a beneficial role as trypanocidal agent ([@B49]). Conversely, NO overproduction via iNOS/NOS2 activity has been implicated in heart injury in *T. cruzi*-infected monkeys and mice ([@B13]). Indeed, high NO concentrations may be detrimental in *T. cruzi* infection by depressing lymphocyte functions, which could favour parasite survival and promoting heart denervation and myocardial cell dysfunction ([@B49], [@B43]). Interestingly, our data support that *T. cruzi*-infected C3H/He mice present higher serum NO concentrations than C57BL/6 mice, paralleling the severity of heart injury and electrical abnormalities.

The pathophysiology of Chagas' heart disease is not fully understood. Previous studies did not ignore the influence of host factors, but supported the importance of the parasite strain as a crucial factor in determining cardiac lesions in mice, particularly with regards to a biological Type III strain ([@B4]) that is currently viewed as the genotypic *T. cruzi* Type I strain ([@B56]). Our study highlights a potential contribution of the immune response, as illustrated by the variable degrees of TNF and NO production in the Colombian-infected C57BL/6 and C3H/He mice, as determinant of CCC severity and therefore supporting the influence of host factors in the fate of Chagas' heart disease. However, the cause/consequence relationship between TNF and NO levels in the serum and heart tissue lesion and ECG alterations is not settled. Furthermore, events surrounding the induction of elevated TNF and NO levels in the serum of chronically *T. cruzi*-infected individuals remain to be identified. One cannot rule out the possibility that enhanced levels of TNF and NO and cardiac damage are all consequences of a more severe acute phase in animals of the C3H/He lineage compared to C57BL/6 mice. If this is true, high levels of TNF and NO would not lead to a more severe pathology, but would rather be a consequence of the more severe pathology in the chronic infection. These ideas deserve to be experimentally challenged.

Altogether, cardiac tissue parasitism and inflammation, heart injury and ECG abnormalities were less intense in the chronically Colombian-infected C57BL/6 compared to C3H/He mice, suggesting that they represent models of mild (C57BL/6) and severe (C3H/He) CCC. Moreover, in these models the CCC severity paralleled TNF and NO levels in the serum ([Fig. 8](#f08){ref-type="fig"}). Therefore, these reasonable experimental models open a window of opportunity to (i) study the pathophysiology of CD and biomarkers of CCC progression and (ii) test therapeutic agents for patients with Chagas' heart disease.

Fig. 8: schematic synthesis of the proposal of experimental models for chronic chagasic cardiomyopathy reproducing the mild (C57BL/6) and severe (C3H/He) manifestations of Chagas' heart disease in association with tumour necrosis factor (TNF) and nitric oxide (NO) levels in the serum.
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[^1]: *a*: analysis of the heart tissue; *b*: analysis of biomarkers in the serum; CK-MB: creatine kinase cardiac MB isoenzyme; Cx43: connexin 43; ECG: electrocardiogram; FN: fibronectin; NI: non-infected; NO: nitric oxide; TNF: tumour necrosis factor; -: no detection of the analysed parameter; +: scores based on the relative expression of the analysed parameter comparing the four groups of mice.
